This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H6N8 Hemagglutinin (HA), C-His
Product Overview
BioVenic's Recombinant Influenza A H6N8 Hemagglutinin (HA), C-His is a recombinant protein expressed from Baculovirus-insect cell. Its predicted molecular weight is 59.3 kDa. The purity is>95% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
The H6 subtype of avian influenza virus (H6 AIV) is the most frequently detected form of AIV in both poultry and wild birds. It leads to significant economic losses in the poultry industry and, more critically, poses a substantial threat to public health due to its potential to infect mammals. One variant within this subtype, H6N8, belongs to the H6 AIV family. The hemagglutinin (HA) protein, a homotrimeric glycoprotein located on the surface of influenza viruses, is crucial for the virus's capacity to infect host organisms.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
References
- Lin, Mingqin, et al. "Evolution and reassortment of H6 subtype avian influenza viruses." Viruses 15.7 (2023): 1547.